-
1
-
-
0032575688
-
The Bcl-2 protein family: Arbiters of cell survival
-
Adams J.M., and Cory S. (1998) The Bcl-2 protein family: Arbiters of cell survival. Science, 281, 1322-1326.
-
(1998)
Science
, vol.281
, pp. 1322-1326
-
-
Adams, J.M.1
Cory, S.2
-
3
-
-
0030713362
-
Anthracyclines in the treatment of cancer. An overview
-
Hortobagyi G.N. (1997) Anthracyclines in the treatment of cancer. An overview. Drugs, 54(Suppl 4), 1-7.
-
(1997)
Drugs
, vol.54
, Issue.SUPPL. 4
, pp. 1-7
-
-
Hortobagyi, G.N.1
-
4
-
-
0035172420
-
Recent advances in the prevention of anthracycline cardiotoxicity in childhood
-
Iarussi D., Indolfi P., Casale F., Coppolino R., Tedesco M.A., and Di Tullio, M.T. (2001) Recent advances in the prevention of anthracycline cardiotoxicity in childhood. Current Medical Chemistry 8, 1649-1660.
-
(2001)
Current Medical Chemistry
, vol.8
, pp. 1649-1660
-
-
Iarussi, D.1
Indolfi, P.2
Casale, F.3
Coppolino, R.4
Tedesco, M.A.5
Di Tullio, M.T.6
-
5
-
-
0031950286
-
Anthracyclines in haematology: Pharmacokinetics and clinical studies
-
Johnson S.A., and Richardson D.S. (1998) Anthracyclines in haematology: Pharmacokinetics and clinical studies. Blood Reviews, 12, 52-71.
-
(1998)
Blood Reviews
, vol.12
, pp. 52-71
-
-
Johnson, S.A.1
Richardson, D.S.2
-
6
-
-
0034778721
-
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells
-
Kaushal G.P., Kaushal V., Hong X., and Shah SN. (2001) Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney International, 60, 1726-1736.
-
(2001)
Kidney International
, vol.60
, pp. 1726-1736
-
-
Kaushal, G.P.1
Kaushal, V.2
Hong, X.3
Shah, S.N.4
-
7
-
-
4644316831
-
Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology
-
Kaushal V., Kaushal G.P., Melkaveri S.N., and Mehta P. (2004) Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology. Joural of Thrombosis and Haemostay, 2, 327-334.
-
(2004)
Journal of Thrombosis and Haemostay
, vol.2
, pp. 327-334
-
-
Kaushal, V.1
Kaushal, G.P.2
Melkaveri, S.N.3
Mehta, P.4
-
8
-
-
0034721770
-
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species
-
Kotamraju S., Konorev E.A., Joseph J., and Kalyanaraman B. (2000) Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. Journal of Biological Chemistry 275, 33585-33592.
-
(2000)
Journal of Biological Chemistry
, vol.275
, pp. 33585-33592
-
-
Kotamraju, S.1
Konorev, E.A.2
Joseph, J.3
Kalyanaraman, B.4
-
10
-
-
0034523687
-
The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
-
Kwok J.C., and Richardson D.R. (2000) The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity. Redox Report, 5, 317-324.
-
(2000)
Redox Report
, vol.5
, pp. 317-324
-
-
Kwok, J.C.1
Richardson, D.R.2
-
11
-
-
0037192824
-
Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism
-
Lorenzo E., Ruiz-Ruiz C., Quesada A.J., Hernandez G., Rodriguez A., Lopez-Rivas A., and Redondo J.M. (2002) Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. Journal of Biological Chemistry, 277, 10883-10892.
-
(2002)
Journal of Biological Chemistry
, vol.277
, pp. 10883-10892
-
-
Lorenzo, E.1
Ruiz-Ruiz, C.2
Quesada, A.J.3
Hernandez, G.4
Rodriguez, A.5
Lopez-Rivas, A.6
Redondo, J.M.7
-
12
-
-
0025051505
-
Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses
-
Olson R.D., and Mushlin P.S. (1990) Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses. FASEB Journal, 4, 3076-3086.
-
(1990)
FASEB Journal
, vol.4
, pp. 3076-3086
-
-
Olson, R.D.1
Mushlin, P.S.2
-
13
-
-
0141786833
-
Cardiac safety of liposomal anthracyclines
-
Safra T. (2003) Cardiac safety of liposomal anthracyclines. Oncologist, 8 (Suppl 2), 17-24.
-
(2003)
Oncologist
, vol.8
, Issue.SUPPL. 2
, pp. 17-24
-
-
Safra, T.1
-
14
-
-
0033113566
-
Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer
-
The Provincial Systemic Treatment Disease Site Group
-
Seymour L., Bramwell V., and Moran L.A. (1999) Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group. Cancer Prevention and Control 3, 145-159.
-
(1999)
Cancer Prevention and Control
, vol.3
, pp. 145-159
-
-
Seymour, L.1
Bramwell, V.2
Moran, L.A.3
-
15
-
-
0031722185
-
Strategies for reduction of anthracycline cardiac toxicity
-
Speyer J., and Wasserheit C. (1998) Strategies for reduction of anthracycline cardiac toxicity. Seminars in Oncology, 25, 525-537.
-
(1998)
Seminars in Oncology
, vol.25
, pp. 525-537
-
-
Speyer, J.1
Wasserheit, C.2
-
16
-
-
0030904096
-
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
-
Swain S.M., Whaley F.S., Gerber M.C., Weisberg S., York M., Spicer D., Jones S.E., Wadler S., Desai A., Vogel C., Speyer J., Mittelman A., Reddy S., Pendergrass K., Velez-Garcia E., Ewer M.S., Bianchine J.R., and Gams R.A. (1997) Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. Journal of Clinical Oncology, 15, 1318-1332.
-
(1997)
Journal of Clinical Oncology
, vol.15
, pp. 1318-1332
-
-
Swain, S.M.1
Whaley, F.S.2
Gerber, M.C.3
Weisberg, S.4
York, M.5
Spicer, D.6
Jones, S.E.7
Wadler, S.8
Desai, A.9
Vogel, C.10
Speyer, J.11
Mittelman, A.12
Reddy, S.13
Pendergrass, K.14
Velez-Garcia, E.15
Ewer, M.S.16
Bianchine, J.R.17
Gams, R.A.18
-
17
-
-
0141842640
-
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity
-
Swift L., McHowat J., and Sarvazyan N. (2003) Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. Cancer Research, 63, 5992-5998.
-
(2003)
Cancer Research
, vol.63
, pp. 5992-5998
-
-
Swift, L.1
McHowat, J.2
Sarvazyan, N.3
-
18
-
-
2342488025
-
Cardiac profiles of liposomal anthracyclines
-
Theodoulou M., and Hudis C. (2004) Cardiac profiles of liposomal anthracyclines. Cancer, 100, 2052-2063.
-
(2004)
Cancer
, vol.100
, pp. 2052-2063
-
-
Theodoulou, M.1
Hudis, C.2
-
20
-
-
2942616456
-
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways
-
Wang S., Konorev E.A., Kotamraju S., Joseph J., Kalivendi S., and Kalyanaraman, B. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways. Journal of Biological Chemistry 279, 25535-25543.
-
(2004)
Journal of Biological Chemistry
, vol.279
, pp. 25535-25543
-
-
Wang, S.1
Konorev, E.A.2
Kotamraju, S.3
Joseph, J.4
Kalivendi, S.5
Kalyanaraman, B.6
-
21
-
-
0026714331
-
The anthracyclines: Will we ever find a better doxorubicin?
-
Weiss R.B. (1992) The anthracyclines: Will we ever find a better doxorubicin? Seminars in Oncology, 19, 670-686.
-
(1992)
Seminars in Oncology
, vol.19
, pp. 670-686
-
-
Weiss, R.B.1
-
22
-
-
0034063979
-
Anthracycline-induced cardiotoxicity: Clinical course, risk factors, pathogenesis, detection and prevention - Review of the literature
-
Wojtacki J., Lewicka-Nowak E., and Lesniewski-Kmak K. (2000) Anthracycline-induced cardiotoxicity: Clinical course, risk factors, pathogenesis, detection and prevention - review of the literature. Medical Science Monitor 6, 411-420.
-
(2000)
Medical Science Monitor
, vol.6
, pp. 411-420
-
-
Wojtacki, J.1
Lewicka-Nowak, E.2
Lesniewski-Kmak, K.3
-
23
-
-
0032724653
-
Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation
-
Wolf B.B., Schuler M., Echeverri F., and Green D.R. (1999) Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. Journal of Biological Chemistry, 274, 30651-30656.
-
(1999)
Journal of Biological Chemistry
, vol.274
, pp. 30651-30656
-
-
Wolf, B.B.1
Schuler, M.2
Echeverri, F.3
Green, D.R.4
-
24
-
-
0036901361
-
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: In vitro and In vivo studies
-
Wu S., Ko Y.S., Teng M.S., Ko Y.L., Hsu L.A., Hsueh C., Chou Y.Y., Liew C.C., and Lee Y.S. (2002) Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and In vivo studies. Journal Molecualr and Cellular Cardiology, 34, 1595-1607.
-
(2002)
Journal Molecualr and Cellular Cardiology
, vol.34
, pp. 1595-1607
-
-
Wu, S.1
Ko, Y.S.2
Teng, M.S.3
Ko, Y.L.4
Hsu, L.A.5
Hsueh, C.6
Chou, Y.Y.7
Liew, C.C.8
Lee, Y.S.9
|